• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

1420-04-8 (Niclosamide ethanolamine salt)



Niclosamide ethanolamine salt Niclosamide ethanolamine salt
Name Niclosamide ethanolamine salt
Formula C15H15Cl2N3O5
MW 388.2
CAS No. 1420-04-8
EINECS 215-811-7
Smiles O=C(NC1=CC=C([N+]([O-])=O)C=C1Cl)C2=C(O)C=CC(Cl)=C2.NCCO
Synonyms 2',5-Dichloro-4'-nitrosalicylanilide 2-aminoethanol salt; 5-Chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide 2-aminoethanol salt; 5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide compound with 2-aminoethanol (1:1)
InChI InChI=1S/C13H8Cl2N2O4.C2H7NO/c14-7-1-4-12(18)9(5-7)13(19)16-11-3-2-8(17(20)21)6-10(11)15;3-1-2-4/h1-6,18H,(H,16,19);4H,1-3H2


Yellow solid. Insoluble in water.

Background Information

With slightly better solubility properties compared to Niclosamide (Prod. No. AG-CR1-3643). Antihelminthic, molluscicide and trypanocidal agent that inhibits mitochondrial oxidative phosphorylation and anaerobic ATP production. Anticancer agent with antiproliferative activity in a broad spectrum of cancer cells. Targets and inhibits multiple signaling pathways, including STAT3, NF-kB, Wnt/β-catenin, Notch and mTORC1. Shown to block TNF-α-induced IκBα phosphorylation, translocation of p65 and the expression of NF-κB-regulated genes and elevates reactive oxygen species (ROS) levels. Promotes Frizzled1 internalization, down-regulates the expression of Dishevelled-2 protein and inhibits β-catenin stabilization. Inhibits mTORC1 but not mTORC2 signaling in cells maintained in nutrient-rich conditions. Cell permeable selective STAT3 inhibitor (IC50=0.25μM). Inhibits the activation, nuclear translocation and transactivation of STAT3. Selective over STAT1, STAT5, JAK1, JAK2 and Src kinases. Induces cell cycle arrest, growth inhibition, autophagy and apoptosis. Inhibits S100A4 (Metastasin-1)-induced metastasis in vivo. Inhibits androgen receptor (AR) splice variants. Anti-inflammatory compound. Quorum sensing inhibitor. Broad range antiviral agent that targets acidified endosomes. Antiobesity and antidiabetic agent. Positive allosteric neuropetide Y4 receptor ligand and increases energy expenditure and lipid metabolism through mitochondrial uncoupling. ......by Adipogen Corporation

Protocol(Only for Reference)

Cell Experiment

Animal Experiment


Physical and Chemical Properties

Appearance: EBNumber:EB000037796

Storage condition



Mechanism and Indication

Signaling Pathways
Research Area

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase

Safety Data of Niclosamide ethanolamine salt


Spectral Information


Suppliers List


Related Products

Other Forms of 1420-04-8

Name CAS No Formula MW

Recommended Compounds in

Name CAS No Formula MW

Recommended Compounds in Same Indication

Name CAS No Formula MW

Route of Synthesis



Protocol Reference


More Information

Niclosamide ethanolamine salt

Tags: buy 1420-04-8 IC50 | 1420-04-8 price | 1420-04-8 cost | 1420-04-8 solubility | 1420-04-8 purchase | 1420-04-8 manufacturer | 1420-04-8 research buy | 1420-04-8 order | 1420-04-8 MSDS | 1420-04-8 chemical structure | 1420-04-8 Storage condition | 1420-04-8 molecular weight | 1420-04-8 mw | 1420-04-8 datasheet | 1420-04-8 supplier | 1420-04-8 cell line | 1420-04-8 NMR | 1420-04-8 MS | 1420-04-8 IR | 1420-04-8 solubility | 1420-04-8 Safe information | 1420-04-8 Qc and Spectral Information | 1420-04-8 Clinical Information | 1420-04-8 Clinical Trial | 1420-04-8 Route of Synthesis | 1420-04-8 storage condition | 1420-04-8 diseases and conditions | 1420-04-8 flash point | 1420-04-8 boiling point | 1420-04-8 melting point | 1420-04-8 storage condition | 1420-04-8 brand